The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: Results of a 9 year follow-up

Journal of Hepatology

Volumn 53, Issue 5, 2010, Pages 911-917

  Jones, David E ^a   Al Rifai, Ahmad ^a   Frith, James ^a   Patanwala, Imran ^a   Newton, Julia L ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Biliary; Fatigue; Liver cirrhosis; Outcomes research; Quality of life

Indexed keywords

URSODEOXYCHOLIC ACID;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FATIGUE; FOLLOW UP; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE;

FATIGUE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS, BILIARY; PROPORTIONAL HAZARDS MODELS; QUALITY OF LIFE; URSODEOXYCHOLIC ACID;

EID: 77957343181     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.05.026     Document Type: Article

References (27)

1. M. Prince, A. Chetwynd, W.L. Newman, J.V. Metcalf, and O.F. James Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years Gastroenterology 123 2002 1044 1051
2. H. Jackson, M. Solaymani-Dodara, T.R. Card, G.P. Aithal, R. Logan, and J. West Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study Hepatology 46 2007 1131 1137
3. C. Corpechot, L. Abenavoli, N. Rabahi, Y. Chretien, T. Andreani, and C. Johanet Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis Hepatology 48 2008 871 877
4. A. Pares, L. Caballeria, and J. Rodes Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid Gastroenterology 130 2006 715 720
5. D.E.J. Jones, J.V. Metcalf, J.D. Collier, M.F. Bassendine, and O.F.W. James Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes Hepatology 26 1997 1138 1142
6. M. Solaymani-Dodaran, G.P. Aithal, T.R. Card, and J. West Risk of cardiovascular and cerebrovascular events in primary biliary cirrhosis: a population-based cohort study Am J Gastroenterol 103 2008 2784 2788
7. D. Howel, J.V. Metcalf, J. Gray, W.L. Newman, D.E. Jones, and O.F. James Cancer risk in primary biliary cirrhosis: a study in Northern England Gut 45 1999 756 760
8. M. Longo, A. Crosignani, P.M. Battezzati, C.S. Giussani, P. Invernizzi, and M. Zuin Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis Gut 51 2002 265 269
9. J. Goldblatt, P.J.S. Taylor, T. Lipman, M. Prince, M. Baragiotta, and M.F. Bassendine The true impact of fatigue in primary biliary cirrhosis: a population study Gastroenterology 122 2002 1235 1241
10. D.E. Jones, N. Bhala, J. Burt, J. Goldblatt, M.I. Prince, and J.L. Newton Four year follow-up of fatigue in a geographically-defined primary biliary cirrhosis patient cohort Gut 55 2006 536 541
11. D.E.J. Jones, and J.L. Newton Fatigue-associated mortality in PBC is principally a problem of the over 65s Gut 2007 1165 1166
12. J.V. Metcalf, and O.F.W. James The geoepidemiology of primary biliary cirrhosis Semin Liver Dis 17 1996 13 22
13. O.F.W. James, R. Bhopal, D. Howel, J. Gray, A.D. Burt, and J.V. Metcalf Primary biliary cirrhosis once rare, now common in the UK? Hepatology 30 1999 390 394
14. J. Fisk, P. Ritvo, L. Ross, D. Haase, T. Marrie, and W. Sclech Measuring the functional impact of fatigue: initial validation of the Fatigue Impact Scale Clin Infect Dis 18 1994 S79 S83
15. M.I. Prince, O.F.W. James, N.P. Holland, and D.E.J. Jones Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use J Hepatol 32 2000 368 373
16. D.E.J. Jones, K. Sutcliffe, J. Pairman, K. Wilton, and J.L. Newton An integrated care pathway improves quality of life in primary biliary cirrhosis QJM 101 2008 535 543
17. A. Jacoby, A. Rannard, D. Buck, N. Bhala, J.L. Newton, and O.F.W. James Development, validation and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis Gut 54 2005 1622 1629
18. J.L. Newton, N. Bhala, J. Burt, and D.E.J. Jones Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure J Hepatol 44 2006 776 782
19. K. Cauch-Dudek, S. Abbey, D.E. Stewart, and E.J. Heathcote Fatigue in primary biliary cirrhosis Gut 43 1998 705 710
20. P.M. Huet, J. Deslauriers, A. Tran, C. Faucher, and J. Charbonneau Impact of fatigue on the quality of life in patients with primary biliary cirrhosis Am J Gastroenterol 95 2000 760 767
21. R.E. Poupon, Y. Chretien, O. Chazouilleres, R. Poupon, and J. Chwalow Quality of life in patients with primary biliary cirrhosis Hepatology 40 2004 489 494
22. K. Harada, J. Van de Water, P.S. Leung, R.L. Coppel, A.A. Ansari, and Y. Nakanuma In situ nucleic acid hybridisation of cytokines in primary biliary cirrhosis: predominance of the Th1 subset Hepatology 25 1997 791 796
23. T. Yokoyama, A. Komori, M. Nakamurs, Y. Takii, T. Kamihara, and S. Shimoda Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NFκB and-MAPK signaling pathways Liver Int 26 2006 467 476
24. S.M. Kerfoot, C. D'Mello, H. Nguyen, N.N. Ajuebor, P. Kupes, and T. Lee TNF-alpha secreting monocytes are recruited into the brain of cholestatic mice Hepatology 43 2006 154 162
25. A.-M. Kampoli, D. Tousoulis, C. Antoniades, G. Siasos, and C. Stefanadis Biomarkers of premature atherosclerosis Trends Mol Med 15 2009 323 332
26. I. Bautmans, R. Njemini, M. Lambert, C. Demanet, and T. Mets Circulating acute phase mediators and skeletal muscle performance in hospitalized geriatric patients J Gerontol A Biol Sci Med Sci 60 2005 361 367
27. S.E. Hardy, and S.A. Studenski Fatigue predicts mortality in older adults J Am Geriatr Soc 56 2008 1910 1914